BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1835966)

  • 1. Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats.
    Bahgat M; Anis HH; Peyman GA; Farahat HG; Parry GJ; Khoobehi B
    Int Ophthalmol; 1991 Sep; 15(5):335-41. PubMed ID: 1835966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pyridoxine on the blood-retina barrier in experimentally induced hyperglycemia in rats.
    Anis HH; Bahgat M; Peyman GA; Farahat HG; Parry GJ; Khoobehi B
    Can J Ophthalmol; 1991 Dec; 26(7):354-7. PubMed ID: 1837242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of aminoguanidine on the blood-retinal barrier in streptozocin-induced diabetic rats.
    Cho HK; Kozu H; Peyman GA; Parry GJ; Khoobehi B
    Ophthalmic Surg; 1991 Jan; 22(1):44-7. PubMed ID: 1826545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of metabolic control on the blood-retinal barrier in streptozocin diabetic rats.
    Kernell A; Dahlkvist H; Arnqvist H; Ludvigsson J
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):179-81. PubMed ID: 15835015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous fluorophotometry in rats with streptozocin-induced diabetes.
    Vine AK; Kisly AM; Betz AL; Howatt WF
    Arch Ophthalmol; 1984 Jul; 102(7):1083-5. PubMed ID: 6743087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous fluorophotometry in three models of experimental diabetes mellitus.
    Smith SS; Ashburn FS; Pilkerton AR; Recant L
    Retina; 1982; 2(2):121-5. PubMed ID: 6217532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcein fluorophotometry in streptozocin-induced diabetic rats.
    Golshani MR; Khoobehi B; Peyman GA; Aras C
    Ophthalmic Surg; 1994 Aug; 25(8):526-31. PubMed ID: 7970535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
    Do carmo A; Ramos P; Reis A; Proença R; Cunha-vaz JG
    Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic vitreous fluorophotometry in experimental diabetes.
    Jones CW; Cunha-Vaz J; Zweig KO; Stein M
    Arch Ophthalmol; 1979 Oct; 97(10):1941-3. PubMed ID: 485921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats.
    Kaufmann F; Lacoste C
    Diabetologia; 1986 Mar; 29(3):175-80. PubMed ID: 3516774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorophotometry. II. Streptozocin-treated guinea pigs.
    Klein R; Engerman RL; Ernest JT
    Arch Ophthalmol; 1980 Dec; 98(12):2233-4. PubMed ID: 7447783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin treatment on the blood-retinal barrier in rats with streptozocin-induced diabetes.
    Kernell A; Arnqvist H
    Arch Ophthalmol; 1983 Jun; 101(6):968-70. PubMed ID: 6344848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes.
    Enea NA; Hollis TM; Kern JA; Gardner TW
    Arch Ophthalmol; 1989 Feb; 107(2):270-4. PubMed ID: 2521787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
    Knudsen LL; Olsen T; Nielsen-Kudsk F
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of vitreous fluorophotometry in patients with type 1 diabetes mellitus.
    Jager J; Tromp A; Hooymans JM; Reitsma WD; Smit AJ
    Ophthalmologica; 1997; 211(4):209-13. PubMed ID: 9216008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of the blood-retinal barrier in experimental diabetes. Vitreous fluorophotometry using carboxyfluorescein and fluorescein.
    Blair NP; Jones CW; Rusin MM
    Arch Ophthalmol; 1984 Dec; 102(12):1810-4. PubMed ID: 6508620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
    Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
    Retina; 1987; 7(3):170-6. PubMed ID: 3423432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
    Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G
    Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
    Engler CB; Sander B; Larsen M; Dalgaard P; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
    Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.